ResearcherUniversity Medical Center Hamburg-EppendorfNo recent work listed
Matthias Reeh
Matched on ORCID iD 0000-0001-9111-3905; OpenAlex author ID A5050660231. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper
Papers 6
- The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC. Co-author DOI 10.3390/cancers14163998↗
- Evaluation of the Hamburg-Glasgow Classification in Pancreatic Cancer: Preoperative Staging by Combining Disseminated Tumor Load and Systemic Inflammation. Last author DOI 10.3390/cancers13235942↗
- Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. Co-author DOI 10.1016/j.ejso.2018.12.012↗
- HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer. Co-author DOI 10.1007/s10495-016-1332-4↗
- Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survival. Co-author DOI 10.1002/ijc.26439↗
- Multivisceral resections in pancreatic cancer: identification of risk factors. First author DOI 10.1007/s00268-011-1263-8↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tarik Ghadban · 3 shared papers, 2017–2022 · strength 0.39
- Paper The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in … DOI 10.3390/cancers14163998↗
- Paper Evaluation of the Hamburg-Glasgow Classification in Pancreatic Cancer: Preoperative Staging by Combining Disseminated T… DOI 10.3390/cancers13235942↗
- Paper HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer. DOI 10.1007/s10495-016-1332-4↗
- Jakob Robert Izbicki · 5 shared papers, 2011–2021 · strength 0.34
- Paper Evaluation of the Hamburg-Glasgow Classification in Pancreatic Cancer: Preoperative Staging by Combining Disseminated T… DOI 10.3390/cancers13235942↗
- Paper Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. DOI 10.1016/j.ejso.2018.12.012↗
- Paper HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer. DOI 10.1007/s10495-016-1332-4↗
- Cenap Güngör · 2 shared papers, 2017–2022 · strength 0.26
- Faik Güntac Uzunoglu · 2 shared papers, 2019–2021 · strength 0.21
- Paper Evaluation of the Hamburg-Glasgow Classification in Pancreatic Cancer: Preoperative Staging by Combining Disseminated T… DOI 10.3390/cancers13235942↗
- Paper Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. DOI 10.1016/j.ejso.2018.12.012↗
- Dan Wang · 1 shared paper, 2022 · strength 0.19
- Yuqiang Li · 1 shared paper, 2022 · strength 0.19
- Heming Ge · 1 shared paper, 2022 · strength 0.19
- Katharina E. Effenberger · 2 shared papers, 2012–2021 · strength 0.16
- Thaer S. A. Abdalla · 1 shared paper, 2021 · strength 0.13
- Maximilian Bockhorn · 3 shared papers, 2011–2019 · strength 0.13
- Paper Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. DOI 10.1016/j.ejso.2018.12.012↗
- Paper Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survival. DOI 10.1002/ijc.26439↗
- Paper Multivisceral resections in pancreatic cancer: identification of risk factors. DOI 10.1007/s00268-011-1263-8↗
- Yogesh Kumar Vashist · 3 shared papers, 2011–2017 · strength 0.12
- Paper HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer. DOI 10.1007/s10495-016-1332-4↗
- Paper Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survival. DOI 10.1002/ijc.26439↗
- Paper Multivisceral resections in pancreatic cancer: identification of risk factors. DOI 10.1007/s00268-011-1263-8↗
- Giuseppe Malleo · 1 shared paper, 2019 · strength 0.08
- Mustapha Adham · 1 shared paper, 2019 · strength 0.08
- Laura Maggino · 1 shared paper, 2019 · strength 0.08
- Waldemar H. Uhl · 1 shared paper, 2019 · strength 0.08
- Julie Périnel · 1 shared paper, 2019 · strength 0.08
- Alessandro Zerbi · 1 shared paper, 2019 · strength 0.08
- Francesca Gavazzi · 1 shared paper, 2019 · strength 0.08
- Claudio Bassi · 1 shared paper, 2019 · strength 0.08
- Roberto Salvia · 1 shared paper, 2019 · strength 0.08
- Ulrich Friedrich Wellner · 1 shared paper, 2017 · strength 0.07
- Michael Tachezy · 2 shared papers, 2011–2012 · strength 0.06
- Emre F. Yekebas · 1 shared paper, 2011 · strength 0.03
- Florian Gebauer · 1 shared paper, 2011 · strength 0.03
- Christoph M. Burdelski · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.